Fluctuations of plasma β2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells

G. Giannella; E. Pelosi-Testa; P. Carlini; D. Habetswallner; E. Montesoro; A. Camagna; V. Calzini; E. M. Ruggeri; M. G. Arena; R. Masciulli; D. Bulgarini; P. Samoggia; S. Di Folco; G. Petrillo; M. G. Sofra; G. Boccoli; G. Mastroberardino; F. Calabresi; U. Testa; C. Peschle

Fluctuations of plasma β2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells

G. Giannella, E. Pelosi-Testa, P. Carlini, D. Habetswallner, E. Montesoro, A. Camagna, V. Calzini, E. M. Ruggeri, M. G. Arena, R. Masciulli, D. Bulgarini, P. Samoggia, S. Di Folco, G. Petrillo, M. G. Sofra, G. Boccoli, G. Mastroberardino, F. Calabresi, U. Testa, C. Peschle

Istituto Regina Elena

Research output: Contribution to journal › Article › peer-review

Abstract

We report the serum levels of soluble interleukin 2 receptor (sIL2R), β2-microglobulin (β2-M) and interferon-γ (IFN-γ) in patients undergoing adoptive immunotherapy with rIL 2 and lymphocyte-activated killer (LAK) cells. Our results indicate that rIL2 induced a marked increase of the serum concentration of these markers, although this increase varied considerably for different individuals. Parallel studies with the same patients also showed a marked rise in the number of IL 2R⁺ lymphocytes: the IL2Rs expressed on these cells were mainly of the 'low affinity' type. We suggest that evaluation of these markers may allow the monitoring of immune system activation induced by rIL2 in patients undergoing adoptive rIL2 and LAK cell immunotherapy.

Original language	English
Pages (from-to)	305-315
Number of pages	11
Journal	Immunobiology
Volume	178
Issue number	4-5
Publication status	Published - 1989

ASJC Scopus subject areas

Immunology

Fingerprint Dive into the research topics of 'Fluctuations of plasma β2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells'. Together they form a unique fingerprint.

Cite this

Giannella, G., Pelosi-Testa, E., Carlini, P., Habetswallner, D., Montesoro, E., Camagna, A., Calzini, V., Ruggeri, E. M., Arena, M. G., Masciulli, R., Bulgarini, D., Samoggia, P., Di Folco, S., Petrillo, G., Sofra, M. G., Boccoli, G., Mastroberardino, G., Calabresi, F., Testa, U., & Peschle, C. (1989). Fluctuations of plasma β2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells. Immunobiology, 178(4-5), 305-315.

Fluctuations of plasma β2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells. / Giannella, G.; Pelosi-Testa, E.; Carlini, P.; Habetswallner, D.; Montesoro, E.; Camagna, A.; Calzini, V.; Ruggeri, E. M.; Arena, M. G.; Masciulli, R.; Bulgarini, D.; Samoggia, P.; Di Folco, S.; Petrillo, G.; Sofra, M. G.; Boccoli, G.; Mastroberardino, G.; Calabresi, F.; Testa, U.; Peschle, C.

In: Immunobiology, Vol. 178, No. 4-5, 1989, p. 305-315.

Research output: Contribution to journal › Article › peer-review

Giannella, G, Pelosi-Testa, E, Carlini, P, Habetswallner, D, Montesoro, E, Camagna, A, Calzini, V, Ruggeri, EM, Arena, MG, Masciulli, R, Bulgarini, D, Samoggia, P, Di Folco, S, Petrillo, G, Sofra, MG, Boccoli, G, Mastroberardino, G, Calabresi, F, Testa, U & Peschle, C 1989, 'Fluctuations of plasma β2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells', Immunobiology, vol. 178, no. 4-5, pp. 305-315.

Giannella, G. ; Pelosi-Testa, E. ; Carlini, P. ; Habetswallner, D. ; Montesoro, E. ; Camagna, A. ; Calzini, V. ; Ruggeri, E. M. ; Arena, M. G. ; Masciulli, R. ; Bulgarini, D. ; Samoggia, P. ; Di Folco, S. ; Petrillo, G. ; Sofra, M. G. ; Boccoli, G. ; Mastroberardino, G. ; Calabresi, F. ; Testa, U. ; Peschle, C. / Fluctuations of plasma β2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells. In: Immunobiology. 1989 ; Vol. 178, No. 4-5. pp. 305-315.

@article{924e57f1cd914b3c85a199650cded5ab,

title = "Fluctuations of plasma β2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells",

abstract = "We report the serum levels of soluble interleukin 2 receptor (sIL2R), β2-microglobulin (β2-M) and interferon-γ (IFN-γ) in patients undergoing adoptive immunotherapy with rIL 2 and lymphocyte-activated killer (LAK) cells. Our results indicate that rIL2 induced a marked increase of the serum concentration of these markers, although this increase varied considerably for different individuals. Parallel studies with the same patients also showed a marked rise in the number of IL 2R+ lymphocytes: the IL2Rs expressed on these cells were mainly of the 'low affinity' type. We suggest that evaluation of these markers may allow the monitoring of immune system activation induced by rIL2 in patients undergoing adoptive rIL2 and LAK cell immunotherapy.",

author = "G. Giannella and E. Pelosi-Testa and P. Carlini and D. Habetswallner and E. Montesoro and A. Camagna and V. Calzini and Ruggeri, {E. M.} and Arena, {M. G.} and R. Masciulli and D. Bulgarini and P. Samoggia and {Di Folco}, S. and G. Petrillo and Sofra, {M. G.} and G. Boccoli and G. Mastroberardino and F. Calabresi and U. Testa and C. Peschle",

year = "1989",

language = "English",

volume = "178",

pages = "305--315",

journal = "Immunobiology",

issn = "0171-2985",

publisher = "Urban und Fischer Verlag GmbH und Co. KG",

number = "4-5",

}

TY - JOUR

T1 - Fluctuations of plasma β2-microglobulin, soluble interleukin 2 receptor and interferon-gamma concentrations after adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells

AU - Giannella, G.

AU - Pelosi-Testa, E.

AU - Carlini, P.

AU - Habetswallner, D.

AU - Montesoro, E.

AU - Camagna, A.

AU - Calzini, V.

AU - Ruggeri, E. M.

AU - Arena, M. G.

AU - Masciulli, R.

AU - Bulgarini, D.

AU - Samoggia, P.

AU - Di Folco, S.

AU - Petrillo, G.

AU - Sofra, M. G.

AU - Boccoli, G.

AU - Mastroberardino, G.

AU - Calabresi, F.

AU - Testa, U.

AU - Peschle, C.

PY - 1989

Y1 - 1989

N2 - We report the serum levels of soluble interleukin 2 receptor (sIL2R), β2-microglobulin (β2-M) and interferon-γ (IFN-γ) in patients undergoing adoptive immunotherapy with rIL 2 and lymphocyte-activated killer (LAK) cells. Our results indicate that rIL2 induced a marked increase of the serum concentration of these markers, although this increase varied considerably for different individuals. Parallel studies with the same patients also showed a marked rise in the number of IL 2R+ lymphocytes: the IL2Rs expressed on these cells were mainly of the 'low affinity' type. We suggest that evaluation of these markers may allow the monitoring of immune system activation induced by rIL2 in patients undergoing adoptive rIL2 and LAK cell immunotherapy.

AB - We report the serum levels of soluble interleukin 2 receptor (sIL2R), β2-microglobulin (β2-M) and interferon-γ (IFN-γ) in patients undergoing adoptive immunotherapy with rIL 2 and lymphocyte-activated killer (LAK) cells. Our results indicate that rIL2 induced a marked increase of the serum concentration of these markers, although this increase varied considerably for different individuals. Parallel studies with the same patients also showed a marked rise in the number of IL 2R+ lymphocytes: the IL2Rs expressed on these cells were mainly of the 'low affinity' type. We suggest that evaluation of these markers may allow the monitoring of immune system activation induced by rIL2 in patients undergoing adoptive rIL2 and LAK cell immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0024512094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024512094&partnerID=8YFLogxK

M3 - Article

C2 - 2497064

AN - SCOPUS:0024512094

VL - 178

SP - 305

EP - 315

JO - Immunobiology

JF - Immunobiology

SN - 0171-2985

IS - 4-5

ER -